Garsorasib
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Garsorasib is a pharmaceutical drug used for cancer treatment. It is a selective inhibitor of the enzyme KRAS that has the G12C mutation. In China, it is approved for the treatment of advanced non-small cell lung cancer (NSCLC) carrying the KRAS G12C mutation in patients who have received at least one systemic treatment.
Garsorasib is a pharmaceutical drug used for cancer treatment. It is a selective inhibitor of the enzyme KRAS that has the G12C mutation. In China, it is approved for the treatment of advanced non-small cell lung cancer (NSCLC) carrying the KRAS G12C mutation in patients who have received at least one systemic treatment.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1374092597 under CC BY-SA 4.0; modifications have been made.